Innovation of Liposomal Carriers
Nanologistics develops and manufactures liposomal molecular carriers for the nutraceutical and pharmaceutical industries.
What are we doing?
Liposomal carriers (liposomes) improve the absorption of active molecules and protect both the molecules themselves and the body from unwanted side reactions.
Our company is developing the first multicomponent liposomes, which enable the transfer of various synergistically acting molecules to the same particular place in the body.
Nanologistics designs and develops single-sized liposomes that demonstrate consistent absorption and superior stability compared to those currently on the market.
Our cutting-edge liposomal products are specifically designed to enhance the vitality of cells, providing a powerful boost to overall health and wellbeing. Our RnD data shows a positive correlation between concentration of liposomal Vitamin C and cell viability.
The company won the InoStartas project and received 199 953 Eur of state funding for product development.
We are currently looking for business development partners who could contribute to the growth and development of the company.
The company won the InoStartas project and received 199 953 Eur of state funding for product development.
We are currently looking for business development partners who could contribute to the growth and development of the company.
Who are we?
A Lithuanian Biotechnology company that develops innovative carriers for targeted delivery of active and aggressive molecules in the human body.
The company’s idea was born in 2020 and was established in February 2023. It was founded by three friends and bootstraped with the help of the winning EU project Inostartas.
Who are we?
A Lithuanian Biotechnology company that develops innovative carriers for targeted delivery of active and aggressive molecules in the human body.
The company’s idea was born in 2020 and was established in February 2023. It was founded by three friends and bootstraped with the help of the winning EU project Inostartas.
The following principles guide the team
Scientific thinking
Data-driven decisions
Passion for Business
Friendly relationship
Respect for people and the process
Products and services
For the pharmaceutical industry
- Development of new liposomal carriers for aggressive molecules.
For food supplements, LIQUID liposomes in one size
- Liposomal Iron
- Liposomal Vitamin C
- Liposomal Curcumin
For dietary supplements, single-size DRY liposomes
- Development of new liposomal carriers for aggressive molecules.
Partnerships
We are happy to have a strong partnership with Vytautas Magnus University and the laboratory of Prof. Saulius Šatkauskas.
Saulius Šatkauskas and his colleagues Salvijus Vykertas and Dr. Baltramiejus Jakštys contribute significantly to the project’s success.
VMU KTPC department contributes to responsible project management and preparation of new projects.
We are looking for investment partners willing to contribute to the development and growth of the company’s activities. We seek a contributing partner who believes in liposomal technology and is a person with values close to the team.
We are looking for investment partners willing to contribute to the development and growth of the company’s activities. We seek a contributing partner who believes in liposomal technology and is a person with values close to the team.
Andrius Kočevas
CEO
8 years in biotech, business & product management, leading high competence and performance teams
Edvinas Grauželis
CCO
8 years in food supplement biotech sales, business development, and team management. Certified coach.
Eventas Šaučiūnas
CTO
8 years in industrial-scale product and tech dev, QA, and R&D project management.